RGNX EBITDA Growth
Regenxbio Inc · EBITDA Growth
RGNX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-7.07%period ending
RGNX TTM EBITDA YoY % (-2549.87% → -7.07%)
Year-over-year change
High-resolution chart · PNG
RGNX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -7.0732% | |
| -87.3108% | |
| 32.7769% | |
| 44.9113% | |
| 40.6403% | |
| 48.314% | |
| 17.2201% | |
| 6.7781% | |
| 10.2108% | |
| -0.4052% | |
| 1.9563% | |
| -288.6936% | |
| -272.9554% | |
| -256.7211% | |
| -237.9213% | |
| 169.9355% | |
| 220.2254% | |
| 250.1107% | |
| 282.8817% | |
| -81.3996% | |
| 17.7911% | |
| 31.1172% | |
| 31.7344% | |
| 2.0796% | |
| -63.0927% | |
| -223.0558% | |
| -254.0431% | |
| -237.5977% | |
| -218.7581% | |
| -186.6245% | |
| 225.7968% | |
| 193.9795% | |
| 198.1798% | |
| 168.8793% | |
| -13.716% | |
| -53.9615% | |
| -92.8807% | |
| -149.5787% | |
| -237.723% | |
| -267.7218% | |
| -514.9953% | |
| -73,717.0732% | |
| -2,549.8715% |